People
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
Merck has announced the retirement of Dr. Roy D. Baynes, head of global clinical development and chief medical officer of Merck Research Laboratories.
Like Elizabeth Holmes, Ramesh Balwani faces multiple counts of fraud related to the business practices of Theranos.
Aerium Therapeutics has officially launched following a successful Series A funding round led by seed investor Omega Funds.
In the interim, Daniel Faga will take the helm as president and CEO after Hamza Suria let go of his executive functions.
Less than two months after joining the executive committee of the Voyager Therapeutics Board of Directors, Alfred W. Sandrock Jr. has been named CEO of the company.
Albert Bourla, Pfizer’s CEO, took home a salary of $1.69 million in 2021. To Pfizer, he’s undoubtedly worth it, having led the company to its COVID-19 vaccine success.
Omega Therapeutics is harnessing the power of epigenetics in an unprecedented way and engineering programmable epigenetic mRNA therapeutics to transform medicine in the service of patients.
The data showed mixed end results, but the diagnostics involved in treating Alzheimer’s were the star of the conference.
Following her ouster as CEO of Athira Pharma, Leen Kawas has co-founded Propel Bio Partners, an equity investment firm focused on helping other life sciences companies.
PRESS RELEASES